| Literature DB >> 34948015 |
Soraia Caetano-Silva1, Bigboy H Simbi1, Neil Marr1, Andrew Hibbert1, Steve P Allen1, Andrew A Pitsillides1.
Abstract
Mechanical cues play a vital role in limb skeletal development, yet their influence and underpinning mechanisms in the regulation of endochondral ossification (EO) processes are incompletely defined. Furthermore, interactions between endochondral growth and mechanics and the mTOR/NF-ĸB pathways are yet to be explored. An appreciation of how mechanical cues regulate EO would also clearly be beneficial in the context of fracture healing and bone diseases, where these processes are recapitulated. The study herein addresses the hypothesis that the mTOR/NF-ĸB pathways interact with mechanics to control endochondral growth. To test this, murine embryonic metatarsals were incubated ex vivo in a hydrogel, allowing for the effects of quasi-static loading on longitudinal growth to be assessed. The results showed significant restriction of metatarsal growth under quasi-static loading during a 14-day period and concentration-dependent sensitivity to hydrogel-related restriction. This study also showed that hydrogel-treated metatarsals retain their viability and do not present with increased apoptosis. Metatarsals exhibited reversal of the growth-restriction when co-incubated with mTOR compounds, whilst it was found that these compounds showed no effects under basal culture conditions. Transcriptional changes linked to endochondral growth were assessed and downregulation of Col2 and Acan was observed in hydrogel-treated metatarsi at day 7. Furthermore, cell cycle analyses confirmed the presence of chondrocytes exhibiting S-G2/M arrest. These data indicate that quasi-static load provokes chondrocyte cell cycle arrest, which is partly overcome by mTOR, with a less marked interaction for NF-ĸB regulators.Entities:
Keywords: NF-ĸB; endochondral ossification; hydrogel; loading; mTOR; quasi-static
Mesh:
Substances:
Year: 2021 PMID: 34948015 PMCID: PMC8706285 DOI: 10.3390/ijms222413220
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Effects of mTOR/NF-ĸB compounds and hydrogel on the growth of E17 metatarsi. (a)—differences in total length between control and growth inhibitors LY294002/PD98059. (b)—changes in total, mineralised zone, and cartilage zone lengths in mouse metatarsi at different embryonic and post-natal stages in vivo and comparison with changes during ex vivo maintenance culture. (c)—mTOR modulators, rapamycin, and leucine both somewhat overcome the hydrogel-mediated arrest in longitudinal growth. (d)—quasi-static loading almost completely arrests metatarsal longitudinal growth at days 7 and 14. (e)—hydrogel quasi-static loading shows dose-dependent restriction of longitudinal growth that rapidly switches above dilutions greater than 1:20. Data are presented in intervals that represent the mean and SD. Results were analysed with a linear mixed effect model and ANOVA test according to normality test distribution. Hydro/H—hydrogel; Rap—rapamycin; Leu—leucine; BA—betulinic acid; SC—SC-514. **** p < 0.0001, *** p < 0.001, ** p < 0.01, * p < 0.05, a—control vs. all conditions except hydrogel + leucine p < 0.001, b—control vs. hydrogel + leucine p < 0.05, c—control vs. hydrogel and hydrogel + rapamycin p < 0.0001, d—control vs. hydrogel + BA and hydrogel + SC p < 0.001.
Selected modulators of NF-ĸB and mTOR pathways.
| Compounds | Function | Concentration |
|---|---|---|
| Betulinic acid | NF-ĸB activator | 2.5 µM |
| SC-514 | NF-ĸB inhibitor | 20 µM |
| Leucine | mTOR activator | 10 mM |
| Rapamycin | mTOR inhibitor | 100 nM |
| Vitrogel 3D™ (Hydrogel) | Quasi-static loading | 1:1 dilution |
Figure 2Metatarsi stained for PCNA and Live/Dead cell labelling. (a)—cultured metatarsi in hydrogel show high levels of PCNA staining at day 14. PCNA 3D confocal whole-mount imaging of metatarsi for proliferation assays, showing DAPI (blue box) and PCNA (red box) mean channel intensity per µm3 of volume. Hydrogel displays higher mean values than the control for both. (b)—metatarsi cultured in hydrogel label positively for viable cells at day 14. 2D fluorescence imaging of metatarsi for live/dead assay (viability). Differences in cell death between control and hydrogel using mean intensity of Texas Red channel per µm2 of area (red box) and live cells using mean intensity of FITC channel per µm2 of area (green box). Hydrogel displays less cell death and brighter live staining than controls. These data are a representation of observations made using 3D live/dead exclusion assay in >1 tarsals. For quantification, 1 sample per condition was analysed. Ctrl—control; Hydro—VitroGel3D hydrogel; Scale bar = 5 mm.
Figure 3mRNA expression shows that hydrogel quasi-static loading interacts with the mTOR pathway. (a)—characterisation of multiplex RT-PCR results using principal component analysis, which shows that variance in dataset can be explained mostly by changes in Col2 and Acan mRNA levels. Biplot showing principal component (PC) 1 and 2, Col2 and Acan, respectively, along with their PC scores; this shows that most genes in the EO multiplex behave similarly, except for Vegf, Il6 and Tbsp4. PCs 1 and 2 (Col2 and Acan) together account for 72% of variance in the dataset, which increases to 84% with the addition of PC3 (Col10). Heatmap shows the 13 analysed genes with PC scores and how they correlate. (b)—day 7 Col2 and Acan mRNA levels are downregulated in the hydrogel condition. (c)—Mmp13 mRNA levels at days 7 and 14 show modulation by either leucine (day 7) or rapamycin (day 14). (d)—IL-6 protein levels determined by ELISA in culture supernatants (left). Marked increases in IL-6 levels were seen in media conditioned by metatarsals in hydrogel. Il6 mRNA levels were downregulated by leucine when added to hydrogel (right). For mRNA, n = 2–6 samples per condition. Data are presented as mean and SD. Results were analysed with ANOVA and t-tests according to normality test distribution. IL-6 ELISA was analysed using Grubbs method of outlier calculation on GraphPad Prism. *** p < 0.001, ** p < 0.01, * p < 0.05, # p < 0.05 between control and all conditions. Ctrl—control; Hydro—hydrogel; Rap—rapamycin; Leu—leucine; H + R—hydrogel + rapamycin; H + L—hydrogel + leucine.
Figure 4Representations of PI-labelled P1 and P2–P4 populations as scatter plots and d5, d7 and d14 as histograms. (a)—representation of the PI-labelled P1 population as a scatter plot and d5, d7 and d14 as histograms. Pie charts represent the proportion of the total number of cells in each cell cycle phase (G0/G1, S and G2/M) in cell populations isolated from metatarsals maintained for 5 (left), 7 (middle) and 14 (right) days in the absence (control) and presence (hydro) of hydrogel quasi-static loading conditions. (b)—representation of the PI-labelled P2–P4 populations pooled together as a scatter plot and d5, d7 and d14 pie charts. Pie charts represent the proportion of the total number of cells in each cell cycle phase (G0/G1, S and G2/M) in cell populations isolated from metatarsals maintained for 5 (left), 7 (middle) and 14 (right) days in the absence (control) and presence (hydro) of hydrogel quasi-static loading conditions. Data were analysed using BD FACSDIVA and FlowJo. Ctrl—control; Hydro—hydrogel; d5—day 5; d7—day 7; d14—day 14; SSC-A—side scatter area; FSC-A—forward scatter area; PE-A—phycoerythrin fluorescent dye area; PE-W—phycoerythrin fluorescent dye width.
Summary of the cell cycle analysis of control and hydrogel conditions at days 5, 7 and 14. Hydro—hydrogel; P—population.
| Control vs. Hydro (%) | ||||
|---|---|---|---|---|
| Day/Cycle Phase | P1 | P2 | P3 | P4 |
| Day 5/G0 and G1 | 60.8 vs. 43.9 | 0 | 48.9 vs. 38.3 | 0 |
| 5/S | 12.2 vs. 21.2 | 15.8 vs. 14.6 | 51.1 vs. 61.7 | 0 vs. 9.5 |
| 5/G2 and M | 27 vs. 34.9 | 84.2 vs. 85.4 | 0 | 100 vs. 90.5 |
| Day 7/G0 and G1 | 43.3 vs. 45 | 0 | 55.3 vs. 45.7 | 0 |
| 5/S | 8.7 vs. 9.6 | 2.5 vs. 4.7 | 44.7 vs. 54.3 | 0 |
| 5/G2 and M | 48 vs. 45.5 | 97.5 vs. 95.3 | 0 | 100 |
| Day 14/G0 and G1 | 37.5 vs. 30 | 0 | 54.9 vs. 47.1 | 0 |
| 5/S | 7.7 vs. 8.2 | 2.3 vs. 2.9 | 45.1 vs. 52.9 | 5.5 vs. 3.6 |
| 5/G2 and M | 54.8 vs. 61.8 | 97.7 vs. 97.1 | 0 | 94.5 vs. 96.4 |
List of primers used for multiplex RT-PCR.
| Gene | Sequence (5′-3′) | |
|---|---|---|
|
| F | AGGTGACACTATAGAATAGCTGTGTGTGTGAGTGGCTT |
| R | GTACGACTCACTATAGGGACTCTTTTCTCTGCCTCCGTG | |
|
| F | AGGTGACACTATAGAATAAGGAAGCTGGCAGACCAGTA |
| R | GTACGACTCACTATAGGGACGTTCTTCACCGACTTCCTC | |
|
| F | AGGTGACACTATAGAATAACAGTCCCAACTTCCTGTGC |
| R | GTACGACTCACTATAGGGATAGTTCTCATCATTCCCGGC | |
|
| F | AGGTGACACTATAGAATACACTCAAGGGAGAGGTCCAG |
| R | GTACGACTCACTATAGGGACCCAAGAGAGAAACCTGCTG | |
|
| F | AGGTGACACTATAGAATACCGAACCTTCATCTTGGTGT |
| R | GTACGACTCACTATAGGGACCCCGAGAAACATTGGAGTA | |
|
| F | AGGTGACACTATAGAATATTCAGTCCCCAACTCCAAAC |
| R | GTACGACTCACTATAGGGACGTTTCCCGTGTAACCATCT | |
|
| F | AGGTGACACTATAGAATAAGTTGCCTTCTTGGGACTGA |
| R | GTACGACTCACTATAGGGAAGCCTCCGACTTGTGAAGTG | |
|
| F | AGGTGACACTATAGAATAGCAATTGCAGAAAGTCCACA |
| R | GTACGACTCACTATAGGGACTCGATTGAAAGGCACACAA | |
|
| F | AGGTGACACTATAGAATACCAGAACTTCCCAACCATGT |
| R | GTACGACTCACTATAGGGAGTCTTCCCCGTGTTCTCAAA | |
|
| F | AGGTGACACTATAGAATATTCCTGCTCAGCTACTCCGT |
| R | GTACGACTCACTATAGGGAGGTAGCTCTGATTTCGGCTG | |
|
| F | AGGTGACACTATAGAATAAGGACTGAAATCAGCGGAGA |
| R | GTACGACTCACTATAGGGATGTCTCTGTAGGGTACCGGG | |
|
| F | AGGTGACACTATAGAATAACACTGGTAAGTGGGGCAAG |
| R | GTACGACTCACTATAGGGATCGCAATGGATTGTGTTGTT | |
|
| F | AGGTGACACTATAGAATAGCAGTGGACCACAGTCATTG |
| R | GTACGACTCACTATAGGGACATCGTCTCTTCTTCCTGCC | |
|
| F | AGGTGACACTATAGAATAGGGTGTGAACCACGAGAAAT |
| R | GTACGACTCACTATAGGGAACTGTGGTCATGAGCCCTTC | |
|
| F | AGGTGACACTATAGAATAGTACCACCATGTACCCAGGC |
| R | GTACGACTCACTATAGGGAGTACTTGCGCTCAGGAGGAG |
Figure 5Summary of NF-ĸB/mTOR and interaction with mechanics. Dark green circles—pathway factors; yellow circles—external factors; light green circles—activator compound; orange circles—inhibitor compound; blue circles—IGF-I pathway; purple circles—movement/loading; pink hexagon—readout markers; black arrows—interactions between mTOR, NF-ĸB and AKT; blue arrows—effects of quasi-static loading. BA—betulinic acid; Rap—rapamycin; Leu—leucine; PD—PD98059; LY—LY294002; CNP—C-type natriuretic peptide.